(678) 384-7220
info@geovax.com
About Us
Company
Management
Board of Directors
Scientific Advisory Board
Our Technology
Technology Overview
Publications
Product Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Contact
Contact Us
Careers
News & Media
GeoVax Investor Information
SEC Filings
Group by
None
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
Search:
Clear filters
Year
All
2018
2019
2020
2021
Description
All
8-K
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Annual Report
Current Report
General Statement of Acquisition of Beneficial Ownership
Notice of Effectiveness
Other Definitive Proxy Statement
Other Definitive Proxy Statements
Other Preliminary Proxy Statements
Post-Effective amendments for registration status
Preliminary Proxy Soliciting Materials
Prospectus
Quarterly Report
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
8-K
(1)
No records
2021
02-11
Current Report
8-K
View
8-K
(1)
No records
2021
02-11
Current Report
8-K
View
Current Report
(1)
No records
2019
02-19
8-K
Current Report
View
DEF 14A
(1)
No records
2020
07-07
Other Definitive Proxy Statement
DEF 14A
View
def 14a
(1)
No records
2018
04-27
Other definitive proxy statements
def 14a
View
DEF 14A
(1)
No records
2019
03-01
Other Definitive Proxy Statements
DEF 14A
View
DEF 14A
(1)
No records
2019
03-14
Other Definitive Proxy Statements
DEF 14A
View
DEFA 14
(1)
No records
2020
07-07
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEFA 14
View
DEFA14A
(1)
No records
2018
04-27
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEFA14A
View
EFFECT
(1)
No records
2018
04-03
Notice of Effectiveness
EFFECT
View
About GeoVax
Company
Management
Board of Directors
Scientific Advisory Board
Our Technology
Technology Overview
Publications
Investors
Corporate Profile
News
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Product Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
SUBMIT
Email
Search
About Us
Company
Management
Board of Directors
Scientific Advisory Board
Our Technology
Technology Overview
Publications
Product Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Contact
Contact Us
Careers
News & Media